Pharmacological inhibition of BIIPKC is cardioprotective in late-stage hypertrophy (2011)
Ferreira, Julio Cesar Batista 
; Koyanagi, Tomoyoshi; Palaniyandi, Suresh S; Fajardo, Giovanni; Brum, Patricia Chakur; Mochly-Rosen, Daria
Source: Journal of Molecular and Cellular Cardiology. Unidade: EEFE
Subjects: FARMACOLOGIA, HIPERTENSÃO, INSUFICIÊNCIA CARDÍACA, CARDIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Julio Cesar Batista et al. Pharmacological inhibition of BIIPKC is cardioprotective in late-stage hypertrophy. Journal of Molecular and Cellular Cardiology, v. 51, p. 980-987, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.yjmcc.2011.08.025. Acesso em: 28 abr. 2024.APA
Ferreira, J. C. B., Koyanagi, T., Palaniyandi, S. S., Fajardo, G., Brum, P. C., & Mochly-Rosen, D. (2011). Pharmacological inhibition of BIIPKC is cardioprotective in late-stage hypertrophy. Journal of Molecular and Cellular Cardiology, 51, 980-987. doi:10.1016/j.yjmcc.2011.08.025NLM
Ferreira JCB, Koyanagi T, Palaniyandi SS, Fajardo G, Brum PC, Mochly-Rosen D. Pharmacological inhibition of BIIPKC is cardioprotective in late-stage hypertrophy [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51 980-987.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1016/j.yjmcc.2011.08.025Vancouver
Ferreira JCB, Koyanagi T, Palaniyandi SS, Fajardo G, Brum PC, Mochly-Rosen D. Pharmacological inhibition of BIIPKC is cardioprotective in late-stage hypertrophy [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51 980-987.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1016/j.yjmcc.2011.08.025
